National Longitudinal Study of Neurodevelopmental Consequences of Substance Use
May 27-28, 2014, Conf Room D (main floor)
6001 Executive Boulevard, Bethesda, MD 20892
Participant List
EXPERT PANEL MEMBERS
Louise Arseneault, Ph.D.
Professor of Developmental Psychology
King’s College London
Institute of Psychiatry
MRC Social, Genetic and Developmental Psychiatry Centre
United Kingdom
Frank M. Biro, M.D.
Director of Research,
Adolescent and Transition Medicine
Professor, UC Department of Pediatrics
Cincinnati Children's Hospital Medical Center
Cincinnati, OH 45229
BJ Casey, Ph.D.
The Sackler Professor of Developmental Psychobiology
Professor of Psychology in Neuroscience
Brain and Mind Research Institute
Weill Cornell Medical College
Cornell University
New York, NY 1006
Linda Chang, M.D.
Professor of Medicine
Program Director
Neuroscience and MR Research
Department of Medicine
John A. Burns School of Medicine
University of Hawai'i
Honolulu, HI 96813
Michael E. Charness, M.D.
Chief of Staff
VA Boston Healthcare System
U.S. Department of Veterans Affairs
West Roxbury, MA 02132
Raquel Gur, M.D., Ph.D.
Professor of Psychiatry Neurology and Radiology
Department of Psychiatry
Perelman School of Medicine
University of Pennsylvania
Philadelphia, PA 19104-4283
Rolf Loeber, Ph.D.
Distinguished Professor of Psychiatry
Professor of Psychology, and Epidemiology
Department of Psychiatry
School of Medicine
University of Pittsburgh
Pittsburgh, PA 15213
Robin J. Mermelstein, Ph.D.
Professor of Psychology
Director of Institute for Health Research and Policy
University of Illinois at Chicago
Chicago, IL 60608
Adolf Pfefferbaum, M.D.
Director
Neuroscience Program
Center for Health Sciences
SRI International
Menlo Park, CA 94025-3493
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE ON CHILD HEALTH AND HUMAN DEVELOPMENT
Alan E. Guttmacher, M.D.
Director
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
Bethesda, MD 20892-2425
CRAN STEERING COMMITTEE
Robert Croyle, Ph.D.
Director
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Rockville, MD 20850
George Koob, Ph.D.
Director
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Rockville MD 20874
Nora D. Volkow, M.D.
Director
National Institute on Drug Abuse
National Institutes of Health
Bethesda, MD 20892-9555
CRAN COORDINATING COMMITTEE
Michele Bloch, M.D., Ph.D.
Chief
Tobacco Control Research Branch
Behavioral Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Rockville, MD 20850
Bethany Griffin Deeds, Ph.D.
Deputy Branch Chief
Epidemiology Research Branch
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
National Institutes of Health
Rockville, MD 20852
Matthew Finger
Public Health Analyst
Division of Epidemiology, Services, and Prevention Research
National Institute on Drug Abuse
National Institutes of Health
Bethesda, MD 20892-9589
Glen Morgan, Ph.D.
Program Director
Tobacco Control Research
Behavioral Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Rockville, MD 20850
Peggy Murray, Ph.D.
Director
Global Alcohol Research Program
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Bethesda, MD 20892-9304
Kenneth R. Warren, Ph.D.
Deputy Director
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Bethesda, MD 20892-9304
Susan Weiss, Ph.D.
Associate Director for Scientific Affairs
National Institute on Drug Abuse
National Institutes of Health
Rockville, MD 20852
STUDY PLANNING COMMITTEE
Kathleen C. Anderson, Ph.D.
Acting Director
Division of Developmental Translational Research
National Institute of Mental Health
National Institutes of Health
Rockville, MD 20852
Shelli Avenevoli, Ph.D.
Branch Chief
Developmental Trajectories of Mental Disorders Branch
Division of Developmental Translational Research
National Institute of Mental Health
National Institutes of Health
Rockville, MD 20582
James Bjork, Ph.D.
Health Scientist Administrator
Clinical Neuroscience Branch
Division of Clinical Neuroscience and Behavioral Research
National Institute on Drug Abuse
National Institutes of Health
Rockville, MD 20852
Kevin Conway, Ph.D.
Deputy Director
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse
National Institutes of Health
Rockville, MD 20852
Stacia Friedman-Hill, Ph.D.
Program Director
Division of Developmental Translational Research
National Institute of Mental Health
National Institutes of Health
Bethesda, MD 20892
Lisa Freund, Ph.D.
Branch Chief
Child Development and Behavior Branch
Division of Extramural Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institutes of Health
Bethesda, MD 20892-7510
John A. Matochik, Ph.D.
Program Director
Division of Neuroscience and Behavior
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Bethesda, MD 20892-9304
Antonio Noronha, Ph.D.
Director
Division of Neuroscience and Behavior
National Institute on Alcohol Abuse and Alcoholism
National Institutes of Health
Bethesda, MD 20892-9304
Deborah M. Winn, PhD
Deputy Director
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
Rockville, MD 20850
SCIENCE WRITER
Michele Pearson
Program Analyst
Division of Developmental Translational Research
National Institute of Mental Health
National Institutes of Health
Rockville, MD 20852